BenevolentAI Ltd:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:BenevolentAI Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C12378
◆発行会社(調査会社):GlobalData
◆発行日:2018年12月
◆ページ数:21
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
BenevolentAI Ltd (BenevolentAI) is an artificial intelligence company that focuses on developing and applying artificial intelligence (AI) to produce new medicines for the treatment of diseases with unmet medical needs. The company’s platform enables scientists to design and develop new treatments for patients, using a large amount of extracted and deduced biomedical information. BenevolentAI has capabilities spanning the entire drug development process from early drug discovery to late stage clinical development. The company harnesses AI technology to focus on developing treatments for a wide range of diseases such as glioblastoma, motor neuron disease, sarcopenia and Parkinson’s disease. It has presence in the UK, Belgium and the US. BenevolentAI is headquartered in London, the UK.

BenevolentAI Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
BenevolentAI Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
BenevolentAI Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
BenevolentAI Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
BenevolentAI Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
BenevolentAI Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
BenevolentAI Ltd, Pharmaceuticals & Healthcare, Deal Details 10
Asset Purchase 10
Benevolentai Acquires Cambridge Research Facility from Proximagen 10
Venture Financing 11
BenevolentAI Secures USD115 Million in Venture Financing 11
Partnerships 12
Axxam and Proximagen Enter into Partnership 12
BenevolentAI Partners with MRC Technology 13
Licensing Agreements 14
BenevolentAI Enters into Licensing Agreement with Janssen Pharma 14
F. Hoffmann-La Roche Entered into Licensing Agreement with Proximagen 15
Asset Transactions 16
Benevolentai Acquires Cambridge Research Facility from Proximagen 16
BenevolentAI Ltd – Key Competitors 17
BenevolentAI Ltd – Key Employees 18
BenevolentAI Ltd – Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Recent Developments 20
Government and Public Interest 20
Nov 09, 2017: BenevolentAI: Annual award announced for medical research charities wishing to benefit from artificial intelligence 20
Appendix 21
Methodology 21
About GlobalData 21
Contact Us 21
Disclaimer 21

List of Tables
BenevolentAI Ltd, Pharmaceuticals & Healthcare, Key Facts 2
BenevolentAI Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
BenevolentAI Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
BenevolentAI Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
BenevolentAI Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
BenevolentAI Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Benevolentai Acquires Cambridge Research Facility from Proximagen 10
BenevolentAI Secures USD115 Million in Venture Financing 11
Axxam and Proximagen Enter into Partnership 12
BenevolentAI Partners with MRC Technology 13
BenevolentAI Enters into Licensing Agreement with Janssen Pharma 14
F. Hoffmann-La Roche Entered into Licensing Agreement with Proximagen 15
Benevolentai Acquires Cambridge Research Facility from Proximagen 16
BenevolentAI Ltd, Key Competitors 17
BenevolentAI Ltd, Key Employees 18
BenevolentAI Ltd, Other Locations 19
BenevolentAI Ltd, Subsidiaries 19

List of Figures
BenevolentAI Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
BenevolentAI Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
BenevolentAI Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
BenevolentAI Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
BenevolentAI Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
BenevolentAI Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
BenevolentAI Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
BenevolentAI Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[BenevolentAI Ltd:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • PDC Energy Inc (PDCE):企業の財務・戦略的SWOT分析
    Summary PDC Energy Inc (PDC Energy) is an oil and gas company. It is engaged in production, development, exploration and marketing of crude oil, natural gas and natural gas liquids. The company provides horizontal drilling and low-risk organic development of oil and natural gas reserves from shales …
  • Microchip Technology Incorporated (MCHP):企業の財務・戦略的SWOT分析
    Microchip Technology Incorporated (MCHP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Dr. Reddy’s Laboratories Ltd (DRREDDY):製薬・医療:M&Aディール及び事業提携情報
    Summary Dr. Reddy's Laboratories Ltd (Dr. Reddy's) is a pharmaceutical company which manufactures and markets generic formulations, active pharmaceutical ingredients, biosimilars and proprietary products. The company’s generic products are used for the treatment of conditions such as gastrointestina …
  • Taylor Wimpey Plc:戦略・SWOT・企業財務分析
    Taylor Wimpey Plc - Strategy, SWOT and Corporate Finance Report Summary Taylor Wimpey Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Brainsway Ltd (BRIN):医療機器:M&Aディール及び事業提携情報
    Summary Brainsway Ltd (Brainsway) is a medical device company that develops and markets transcranial magnetic stimulation systems and noninvasive medical device for treatment of neurological and psychopathological disorders. The company provides deep transcranial magnetic stimulation products. It of …
  • DCP Midstream LP (DCP):石油・ガス:M&Aディール及び事業提携情報
    Summary DCP Midstream LP (DCP), formerly DCP Midstream Partners, LP, is a midstream energy company. It gathers, compresses, treats, and processes natural gas; and produces and markets natural gas liquids (NGL). The company also fractionates NGLs, and recovers and sells condensate. DCP transports NGL …
  • Correvio Pharma Corp (COM):製薬・医療:M&Aディール及び事業提携情報
    Summary Correvio Pharma Corp(Correvio) formerly known as Cardiome Pharma Corp, is a specialty pharmaceutical company, which develops and commercializes therapies for the treatment and prevention of cardiovascular diseases. The company’s product portfolio includes two marketed products: Brinavess, fo …
  • Islet Sciences Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Islet Sciences Inc (Islet Sciences) is a drug development company that develops medicines and technologies for the treatment of metabolic diseases. The company's pipeline products include immune modulating small molecule interleukin 12 inhibitors to address disorders associated with inflamma …
  • Sunshine Oilsands Ltd (2012):石油・ガス:M&Aディール及び事業提携情報
    Summary Sunshine Oilsands Ltd (Sunshine Oilsands) is an oil and gas company that develops holdings of oil sands and PN&G leases. The company owns and controls oil sands leases. Its properties include Thickwood, West Ells, Muskwa, Harper, Legend Lake and Portage, among others. Sunshine Oilsands also …
  • Actuant Corporation:企業の戦略・SWOT・財務情報
    Actuant Corporation - Strategy, SWOT and Corporate Finance Report Summary Actuant Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Pacific Energy Ltd (PEA):企業の財務・戦略的SWOT分析
    Summary Pacific Energy Ltd (PEL) operates as a power generation company that develops, operates and maintains renewable energy power stations. The company operates Kalgoorlie Power Systems that operates site locations across Northern Territory, Western Australia and South Australia, among others. It …
  • Uranium Energy Corp:企業の戦略・SWOT・財務情報
    Uranium Energy Corp - Strategy, SWOT and Corporate Finance Report Summary Uranium Energy Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Anglo Pacific Group plc:企業のM&A・事業提携・投資動向
    Anglo Pacific Group plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Anglo Pacific Group plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisition …
  • Transportadora De Gas Del Sur S.A.:企業の戦略・SWOT・財務分析
    Transportadora De Gas Del Sur S.A. - Strategy, SWOT and Corporate Finance Report Summary Transportadora De Gas Del Sur S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Brunel International NV (BRNL):企業の財務・戦略的SWOT分析
    Brunel International NV (BRNL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • KBC Group NV:企業のM&A・事業提携・投資動向
    KBC Group NV - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's KBC Group NV Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, …
  • China North Industries Group Corp:企業の戦略的SWOT分析
    China North Industries Group Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major p …
  • Twenty-First Century Fox Inc. (FOXA):企業の財務・戦略的SWOT分析
    Twenty-First Century Fox Inc. (FOXA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • DormaKaba Holding AG:企業の戦略・SWOT・財務情報
    DormaKaba Holding AG - Strategy, SWOT and Corporate Finance Report Summary DormaKaba Holding AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Bunge North America, Inc.:戦略・SWOT・企業財務分析
    Bunge North America, Inc. - Strategy, SWOT and Corporate Finance Report Summary Bunge North America, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆